Brief: AUM Biosciences Announces Plans To Become A Public Company Via Merger With Mountain Crest Acquisition Corp. V
20/10/2022 10:03
Oct 20 (Reuters) - Mountain Crest Acquisition Corp V
MCAGU.O :
* AUM BIOSCIENCES, A GLOBAL BIOTECHNOLOGY COMPANY DEVELOPING
PRECISION ONCOLOGY THERAPEUTICS, ANNOUNCES PLANS TO BECOME A
PUBLIC COMPANY VIA MERGER WITH MOUNTAIN CREST ACQUISITION CORP.
V
* TRANSACTION REFLECTS A PRE-MONEY EQUITY VALUE OF $400
MILLION
FOR AUM BIOSCIENCES
* COMPANY TO EXPAND US OPERATIONS AND CLINICAL PROGRAMS
* VISHAL DOSHI WILL CONTINUE TO LEAD AS CEO OF PUBLICLY
TRADED
HOLDING ENTITY
* MOUNTAIN CREST ACQUISITION CORP - DEAL IS EXPECTED TO
PROVIDE
$69 MILLION OF GROSS PROCEEDS (ASSUMING NO REDEMPTIONS BY
MOUNTAIN CREST STOCKHOLDERS)
Source text for Eikon: ID:nGNX5v5Gj5
Further company coverage: MCAGU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mountain Crest Acquisition V
See all newsBrief: Mountain Crest Acquisition Corp. V Receives Notification Of Deficiency From Nasdaq Related To Delayed Filing Of Quarterly Reports
Brief: SPAC Mountain Crest Acquisition Corp V Receives Deficiency Notification From Nasdaq On Delayed Filing Of Annual Report, Quarterly Report
Brief: Cubebio Enter Terms Of Potential Business Combination With Mountain Crest Acquisition Corp
Brief: Mountain Crest Acquisition Corp V Got Letter From Nasdaq
Brief: Mountain Crest Acquisition Corp V Says On June 27, Co Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq